Back
Theravance Biopharma Quote, Financials, Valuation and Earnings
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Buy
70
TBPH
Theravance Biopharma
Last Price:
10.04
Seasonality Move:
7.6%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)Theravance Biopharma Price Quote
$10.04
Theravance Biopharma Key Stats
Buy
70
Theravance Biopharma (TBPH)
is a Buy
Day range:
$9.96 - $10.10
52-week range:
$7.44 - $11.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.79
P/B ratio:
2.67%
Volume:
129.7K
Avg. volume:
214.3K
1-year change:
-6.86%
Market cap:
$495.7M
Revenue:
$57.4M
EPS:
$-1.01
How Much Does Theravance Biopharma Make?
-
How Much Are Theravance Biopharma's Sales Annually?
TBPH Revenues are $57.4M -
How Much Profit Does Theravance Biopharma's Make A Year?
TBPH net income is -$55.2M
Is Theravance Biopharma Growing As A Company?
-
What Is Theravance Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is Theravance Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Theravance Biopharma Stock Price Performance
-
Did Theravance Biopharma Stock Go Up Last Month?
Theravance Biopharma share price went up by 10.57% last month -
Did TBPH's Share Price Rise Over The Last Year?
TBPH share price fell by -6.86% over the past 1 year
What Is Theravance Biopharma 52-Week High & Low?
-
What Is Theravance Biopharma’s 52-Week High Share Price?
Theravance Biopharma has traded as high as $11.71 over the past 52 weeks -
What Is Theravance Biopharma’s 52-Week Low Share Price?
Theravance Biopharma has traded as low as $7.44 over the past 52 weeks
Theravance Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Theravance Biopharma?
-
How Much Debt Does Theravance Biopharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Theravance Biopharma Have?
Cash and short term investments quarterly total is $91.4M -
What Is Theravance Biopharma’s Book Value Per Share?
Book value per share is 3.78
Is Theravance Biopharma Cash Flow Positive?
-
What Is TBPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$11.5M -
What Is Theravance Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$32.7M -
What Is Theravance Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.1M
Theravance Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
TBPH return on invested capital is -23.68% -
What Is Theravance Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -13.1% -
What Is TBPH Return On Equity?
ROE is a measure of profitability and is -23.68%
Theravance Biopharma Earnings Date & Stock Price
-
What Is Theravance Biopharma's Stock Price Today?
A single share of TBPH can be purchased today for 10.04 -
What Is Theravance Biopharma’s Stock Symbol?
Theravance Biopharma trades on the nasdaq under the ticker symbol: TBPH -
When Is Theravance Biopharma’s Next Earnings Date?
The next quarterly earnings date for Theravance Biopharma is scheduled on February 26, 2025 -
When Is TBPH's next ex-dividend date?
Theravance Biopharma's next ex-dividend date is December 12, 2024 -
How To Buy Theravance Biopharma Stock?
You can buy Theravance Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Theravance Biopharma Competitors
-
Who Are Theravance Biopharma's Competitors?
Below is a list of companies who compete with Theravance Biopharma or are related in some way:
Theravance Biopharma Dividend Yield
-
What Is TBPH Dividend Yield?
Theravance Biopharma’s dividend yield currently is 0% -
What Is Theravance Biopharma’s Payout Ratio?
Theravance Biopharma’s payout ratio is 0% -
When Did Theravance Biopharma Last Pay A Dividend?
The latest dividend pay date is December 12, 2024 -
What Is Theravance Biopharma’s Dividend Per Share?
Theravance Biopharma pays a dividend of $0.00 per share
Theravance Biopharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 42.9% |
| Revenue: | 7.49% | 9.37% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 13.20 |
| Upside from Last Price: | 31.47% |